Amplifon (OTCMKTS:AMFPF) Upgraded to “Buy” at Jefferies Financial Group

Amplifon (OTCMKTS:AMFPFGet Rating) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research report issued on Wednesday, The Fly reports.

A number of other research firms have also weighed in on AMFPF. Barclays increased their price objective on Amplifon from €30.00 ($32.61) to €33.00 ($35.87) in a research note on Tuesday, November 22nd. Morgan Stanley dropped their price objective on Amplifon from €29.00 ($31.52) to €28.00 ($30.43) in a research note on Friday, October 28th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $30.50.

Amplifon Price Performance

Shares of AMFPF opened at $25.00 on Wednesday. The firm has a market cap of $5.66 billion, a P/E ratio of 26.88 and a beta of 0.49. Amplifon has a 1 year low of $25.00 and a 1 year high of $53.33. The stock has a 50 day simple moving average of $25.11 and a two-hundred day simple moving average of $27.58.

Amplifon Company Profile

(Get Rating)

Amplifon SpA is engaged in the distribution, application, and customization of hearing solutions. It contributes to the development of detection and rehabilitation techniques in otology diagnosis, and management of computerized and integrated auditory systems. The firm operates through the following geographical segments: Europe, Middle East and Africa (EMEA); Americas; and Asia-Pacific.

See Also

The Fly logo

Analyst Recommendations for Amplifon (OTCMKTS:AMFPF)

Receive News & Ratings for Amplifon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplifon and related companies with MarketBeat.com's FREE daily email newsletter.